Topics
CME/CE
Editorial Board
Investigative therapy for melanoma promising
An investigative combination therapy combining chemotherapy and immunotherapy of adoptive cell transfer with tumor infiltrating lymphocytes, followed by interleukin-2, is labor-intensive but a feasible therapy with a high response rate in treated patients, according to researchers.
Related Videos
Related Content
